$FNHI - MUST READ DD (( News/Update coming)) 1. WHAT DOES

New Post Public Reply Private Reply Replies (0) Message Board
PROFIT$
146
$FNHI - MUST READ DD (( News/Update coming))

1. WHAT DOES FNHI DO? 

FNHIs TRUXMART, a wholly owned subsidiary of Franchise Holdings International (FNHI), is taking pickup truck bed covers to a whole new level with creative innovation and technology. 

Truxmart sells a variety of pickup tonneau covers, currently FNHI is working to complete and patent the Alpha Helios which incorporates solar panels into the cover, producing over 400 Watts! 

2. WHO IS THE CEO? 

Steven Rossi is the CEO and majority voter (thru non-convertible preffered shares). Rossi's nickname is "the honest CEO" - this came about due to other CEOs criticizing Rossi for keeping his common share certificates in his drawer and not selling a single share. Rossi doesn't even own a brokerage account according him. He also stated he wouldn't sell a single share whether at 04 or .40 !! 

Rossi is active on twitter: 

Check out Steven Rossi (@thehonest_ceo): https://twitter.com/thehonest_ceo?s=09 

ROSSI works hard and has brought TRUXMART a long way from when it began in 2011. 

3. WHAT IS THE SHARE STRUCTURE 

Due to shareholder requests the CEO has decided to retire 100M of his 112M common shares that he owns - giving himself non convertible preffered shares! See recent PR. 

After appropriate filings with state of NV the OS will be 123M shares! 

4. ANY CONVERTIBLE NOTES? 

No! Two notes were fully retired early 2017, the stock price has bounced back up after these conversions were done due to the potential here. The CEO will no longer accept any convertible notes and looking for funding thru Private Placements! 

5.WHY DOES FNHI HAVE A STOP SIGN 

FNHI is currently undergoing an Audit months in the making for 2016 financials, and subsequently will file 2017 Q1 and Q2. 

6. WHAT WILL HAPPEN NEXT?? 

Upon Audit completion, filing of 10k, Q1, and Q2 FNHI will uplist to OTCQB , uplist to the CSE, which will trigger release of $450k from Gunpowder Capital (interest bearing) , these funds will be used to reach revenue targets of 5-10M in 2017-2018, according to the CEO! 

7. SHORT TERM CATALYSTS MOVING FORWARD 

In addition to mentioned uplists , FNHI will build inventory to grow revenues and potentially enter brick and mortar stores like Autozone ( this will be massive as Autozone orders are huge!) FNHI CEO said with inventory buildup this will be easy! 

We could see FNHI compete with BAK industries which was acquired in 2014 for 125M! 

A potential JV deal on the Alpha Helios cover, producing 400 Watts, with an OEM like TESLA would be massive. These revolutionary covers could be coupled with electric trucks! 

Also another lucrative revenue opportunity is an OEM deal whereby FNHI covers are sold on new trucks! The CEO has expressed interest in this space. 


8.REVENUES 

According to the CEO FNHI currently is experiencing it's highest booked purchase orders to date! The CEO stated short term revenue targets are 5-10 Million! And long term target of 50Million! 

9.MARKET CAP 

Upon completion of noted share retirement, the OS will be 123M with a much smaller float. 

AT .10 /share = MARKET CAP 12.3 Million 
AT .20 /share = MARKET CAP 24.6 Million 

If FNHI meets the goals mentioned above , short term price targets could easily be .25 + 

If FNHI meets long term target revenues of 50Million , we could see dollars per share! 

The potential here is massive and it all begins soon with Audit completion! FNHI MUST READ DD 


$FNHI - 

http://www.franchiseholdingsinternational.com/




$FNHI -

https://www.otcmarkets.com/stock/FNHI/profile

It's only $, play at ur own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 222

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 218

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 288

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 202

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 162

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 228

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 205

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading

Top 5 Most Recently Viewed Articles

Alto Neuroscience, Inc. Faces Class Action Lawsuit Risk

Updated Category News Views 181

Class Action Lawsuit Against Alto Neuroscience, Inc. Alto Neuroscience, Inc. (NYSE: ANRO) is currently facing a class action lawsuit filed by a national shareholder rights litigation firm. This lawsuit revolves around allegations of securities fraud, claiming the company made misleading statements regarding the efficacy of its product ALTO-100 in treating major depressive...

Continue Reading
Hyatt and Playa Hotels Explore Strategic Partnership Options

Updated Category News Views 218

Hyatt Engages in Exclusive Discussions with Playa Hotels Hyatt Hotels (NYSE: H) is currently in exclusive negotiations regarding a potential takeover of Playa Hotels & Resorts (NASDAQ: PLYA) N.V. This engagement marks a significant move for both companies as they explore various strategic options for the $1.2 billion resort operator. The announcement has generated...

Continue Reading
LingoAce Celebrated as Top Innovator in Global Education Market

Updated Category News Views 111

LingoAce Celebrated as Top Innovator in Global Education Market Pioneering Tech-driven, Personalized Learning for over 580,000 Learners Worldwide LingoAce, a prominent global EdTech company, has received recognition as a 2025 Forbes China Influential Brand in Education. This honor was presented during the inaugural 2025 Forbes China Educational Industry Summit,...

Continue Reading
Atea Pharmaceuticals Showcases Promising HCV Treatment Data

Updated Category News Views 138

Innovation in Hepatitis C Treatment by Atea Pharmaceuticals Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) has made a significant impact in the field of antiviral therapeutics through their ongoing research and development efforts. The company recently presented compelling data at The Liver Meeting 2024, highlighting the promising combination of bemnifosbuvir and ruzasvir for...

Continue Reading
NV5 Global Backs Major Coastal Mapping Initiative in New Zealand

Updated Category News Views 197

NV5 Global Secures $4 Million Coastal Mapping Contract NV5 Global, Inc. (NASDAQ: NVEE), a significant player in the professional engineering field, has recently secured a noteworthy contract with Toit? Te Whenua Land Information New Zealand (LINZ) for a $4 million coastal mapping project. This contract is an important milestone in NV5's effort to expand its international...

Continue Reading